Evogene Ltd. (EVGN.TA)
ILA 399.6
(2.72%)
ILA 399.6
(2.72%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -26.5 Million USD | 1.61% |
| 2022 | -26.94 Million USD | 12.96% |
| 2021 | -30.95 Million USD | -24.74% |
| 2020 | -24.81 Million USD | -17.24% |
| 2019 | -21.16 Million USD | -5.89% |
| 2018 | -19.98 Million USD | 8.92% |
| 2017 | -21.94 Million USD | -4.07% |
| 2016 | -21.08 Million USD | -17.68% |
| 2015 | -17.92 Million USD | -17.47% |
| 2014 | -15.25 Million USD | -74.93% |
| 2013 | -8.72 Million USD | -178.98% |
| 2012 | -3.12 Million USD | 1.79% |
| 2011 | -3.18 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -4.08 Million USD | 46.43% |
| 2024 Q2 | -6.1 Million USD | -49.34% |
| 2023 Q4 | -7.62 Million USD | -82.36% |
| 2023 FY | -26.5 Million USD | 1.61% |
| 2023 Q1 | -6.79 Million USD | -79.69% |
| 2023 Q2 | -7.9 Million USD | -16.26% |
| 2023 Q3 | -4.18 Million USD | 47.06% |
| 2022 FY | -26.94 Million USD | 12.96% |
| 2022 Q4 | -3.78 Million USD | 46.71% |
| 2022 Q3 | -7.09 Million USD | 11.37% |
| 2022 Q2 | -8 Million USD | 0.6% |
| 2022 Q1 | -8.05 Million USD | 7.33% |
| 2021 Q3 | -8.55 Million USD | -14.91% |
| 2021 FY | -30.95 Million USD | -24.74% |
| 2021 Q1 | -6.25 Million USD | 12.79% |
| 2021 Q2 | -7.44 Million USD | -18.96% |
| 2021 Q4 | -8.69 Million USD | -1.59% |
| 2020 Q2 | -5.22 Million USD | 23.8% |
| 2020 Q3 | -5.55 Million USD | -6.26% |
| 2020 FY | -24.81 Million USD | -17.24% |
| 2020 Q1 | -6.85 Million USD | 0.33% |
| 2020 Q4 | -7.17 Million USD | -29.25% |
| 2019 Q2 | -4.7 Million USD | -0.73% |
| 2019 Q4 | -6.88 Million USD | -40.06% |
| 2019 Q1 | -4.66 Million USD | 11.35% |
| 2019 FY | -21.16 Million USD | -5.89% |
| 2019 Q3 | -4.91 Million USD | -4.47% |
| 2018 FY | -19.98 Million USD | 8.92% |
| 2018 Q4 | -5.26 Million USD | -3.21% |
| 2018 Q3 | -5.1 Million USD | -9.2% |
| 2018 Q2 | -4.67 Million USD | 5.52% |
| 2018 Q1 | -4.94 Million USD | 17.83% |
| 2017 Q2 | -5.16 Million USD | 1.75% |
| 2017 Q3 | -5.5 Million USD | -6.48% |
| 2017 FY | -21.94 Million USD | -4.07% |
| 2017 Q4 | -6.01 Million USD | -9.4% |
| 2017 Q1 | -5.25 Million USD | 14.52% |
| 2016 Q1 | -4.58 Million USD | 14.62% |
| 2016 Q3 | -5.17 Million USD | 0.17% |
| 2016 FY | -21.08 Million USD | -17.68% |
| 2016 Q4 | -6.15 Million USD | -18.95% |
| 2016 Q2 | -5.18 Million USD | -13.02% |
| 2015 FY | -17.92 Million USD | -17.47% |
| 2015 Q4 | -5.36 Million USD | -41.96% |
| 2015 Q1 | -4.12 Million USD | 10.2% |
| 2015 Q2 | -4.64 Million USD | -12.45% |
| 2015 Q3 | -3.78 Million USD | 18.53% |
| 2014 Q1 | -2.62 Million USD | 35.09% |
| 2014 FY | -15.25 Million USD | -74.93% |
| 2014 Q4 | -4.59 Million USD | -6.76% |
| 2014 Q3 | -4.3 Million USD | -15.5% |
| 2014 Q2 | -3.72 Million USD | -42.02% |
| 2013 Q4 | -4.04 Million USD | -59.97% |
| 2013 Q1 | -582 Thousand USD | 36.74% |
| 2013 FY | -8.72 Million USD | -178.98% |
| 2013 Q2 | -1.56 Million USD | -169.24% |
| 2013 Q3 | -2.52 Million USD | -61.33% |
| 2012 Q2 | -996 Thousand USD | 0.0% |
| 2012 Q3 | -1.08 Million USD | -9.34% |
| 2012 Q4 | -920 Thousand USD | 15.52% |
| 2012 FY | -3.12 Million USD | 1.79% |
| 2011 FY | -3.18 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Matricelf Ltd | -12.59 Million ILA | -110.448% |